ELRAKAYBI, Asmaa, RUESS, Dietrich Alexander, LÜBBERT, Michael, QUANTE, Michael und BECKER, Heiko, 2022. Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment. Freiburg: Universität.
Elsevier - Harvard (with titles)Elrakaybi, A., Ruess, D.A., Lübbert, M., Quante, M., Becker, H., 2022. Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment. Universität, Freiburg. https://doi.org/10.3390/cancers14235926
American Psychological Association 7th editionElrakaybi, A., Ruess, D. A., Lübbert, M., Quante, M., & Becker, H. (ca. 2022). Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment [Cd]. Universität. https://doi.org/10.3390/cancers14235926
Springer - Basic (author-date)Elrakaybi A, Ruess DA, Lübbert M, Quante M, Becker H (2022) Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Elrakaybi, Asmaa/ Ruess, Dietrich Alexander/ Lübbert, Michael/ Quante, Michael/ Becker, Heiko, Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment, Freiburg 2022.